ZEPP
Zepp Health Corporation American depositary shares each representing sixteen Class A
$49.18
-$2.12(-4.13%)
66
Overall
--
Value
66
Tech
--
Quality
Market Cap
$671.99M
Volume
208.92K
52W Range
$2.13 - $55.99
Target Price
$60.23
Order:
Income Statement
| Metric | Trend | Chart | 2017 Dec | 2018 Dec | 2019 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||
| Total Revenue | $2.0B | $3.6B | $5.8B | $6.3B | $4.1B | $352.9M | $182.6M | ||
| Total Revenue | $2.0B | $3.6B | $5.8B | $6.3B | $4.1B | $352.9M | $182.6M | ||
| COST OF GOODS SOLD | |||||||||
| Cost of Revenue | $-1.6B | $-2.7B | $-4.3B | $4.9B | $3.3B | $260.5M | $112.4M | ||
| GROSS PROFIT | |||||||||
| Gross Profit | $494.7M | $939.5M | $1.5B | $1.3B | $803.1M | $92.4M | $70.2M | ||
| OPERATING EXPENSES | |||||||||
| Operating Expenses | $-312.7M | $-573.7M | $-861.3M | $-190.1M | $1.2B | $122.8M | $117.5M | ||
| Research & Development | $153.8M | $263.2M | $430.8M | $80.8M | $75.0M | $51.5M | $46.2M | ||
| Research Expense | $153.8M | $263.2M | $430.8M | $80.8M | $75.0M | $51.5M | $46.2M | ||
| Selling, General & Administrative | $239.2M | $310.5M | $432.9M | $109.3M | $100.9M | $71.3M | $71.3M | ||
| Selling & Marketing Expenses | $124.3M | $96.5M | $182.0M | $68.8M | $66.7M | $44.5M | $46.5M | ||
| General & Administrative Expenses | $114.9M | $214.0M | $250.9M | $40.5M | $34.2M | $26.8M | $24.9M | ||
| Promotion & Advertising | -- | $-25.4M | $-72.3M | -- | $-172.6M | -- | -- | ||
| Salaries & Wages | $-62.8M | $-134.7M | $-55.1M | -- | $-49.1M | -- | -- | ||
| Depreciation & Amortization | $-3.5M | $-5.8M | $-9.4M | -- | $-41.4M | -- | -- | ||
| Depreciation & Amortization | $-3.5M | $-5.8M | $-9.4M | -- | $-41.4M | -- | -- | ||
| Amortization | $-175.0K | $-443.0K | $-7.8M | -- | $-17.2M | -- | -- | ||
| Other Operating Expenses | $-312.7M | $-573.7M | $-861.3M | -- | $-37.4M | -- | -- | ||
| OPERATING INCOME | |||||||||
| Operating income | $101.7M | $365.7M | $604.0M | $5.3B | $3.5B | $-30.4M | $-47.3M | ||
| EBITDA | $195.6M | $392.8M | $669.6M | $203.4M | $-256.9M | $-20.2M | $-47.3M | ||
| NON-OPERATING ITEMS | |||||||||
| Interest Expense (Non-Operating) | -- | -- | -- | $44.9M | $57.0M | $6.8M | $5.6M | ||
| Intinc | -- | -- | -- | $2.6M | $1.8M | $3.1M | $3.7M | ||
| Net Non-Operating Interest Income/Expense | -- | -- | -- | $-4.4M | $44.7M | $-3.7M | $-1.9M | ||
| Gain on Sale of Securities | $2.4M | $8.1M | $1.8M | $2.1M | $7.6M | $109.0K | -- | ||
| Other Income/Expense | $-9.7M | $-18.6M | $-11.3M | $-12.9M | $82.4M | $203.0K | $-1.4M | ||
| Other Special Charges | $4.6M | $8.8M | $13.2M | $4.3M | $6.4M | $-525.0K | $-656.0K | ||
| SPECIAL ITEMS | |||||||||
| Restructring And Mn A Income | -- | $12.2M | -- | -- | -- | -- | -- | ||
| Special Income Charges | -- | $-19.8M | $-2.6M | -- | -- | $-313.0K | $-10.1M | ||
| Impairment of Capital Assets | -- | -- | -- | -- | -- | $313.0K | $10.1M | ||
| PRE-TAX INCOME | |||||||||
| EBIT | $191.9M | $386.6M | $652.4M | $151.6M | $-315.5M | $-27.9M | $-52.4M | ||
| Pre-Tax Income | $191.9M | $386.6M | $652.4M | $106.7M | $-372.5M | $-34.6M | $-57.9M | ||
| INCOME TAX | |||||||||
| Tax Provision | $27.6M | $52.0M | $77.9M | $10.7M | $-65.9M | $3.5M | $17.9M | ||
| NET INCOME | |||||||||
| Net Income | $87.4M | $327.8M | $572.7M | $137.8M | $-288.3M | $-38.1M | $-75.7M | ||
| Net Income (Continuing Operations) | $87.4M | $327.8M | $572.7M | $5.3B | $-289.0M | $-38.2M | $-75.8M | ||
| Net Income (Discontinued Operations) | $87.4M | $327.8M | $572.7M | $137.8M | $-288.3M | $-38.1M | $-75.7M | ||
| Net Income (Common Stockholders) | $46.1M | $113.5M | $572.7M | $137.8M | $-288.3M | $-38.1M | $-75.7M | ||
| Normalized Income | -- | -- | -- | -- | -- | $-25.1M | $-47.2M | ||
| TOTALS | |||||||||
| Total Expenses | $-1.9B | $-3.3B | $-5.2B | $-966.0M | $4.6B | $383.3M | $229.9M | ||
| SHARE & EPS DATA | |||||||||
| Average Shares Outstanding | $4.2M | $13.2M | $15.2M | $15.8M | $15.4M | $15.2M | $16.2M | ||
| Average Shares Outstanding (Diluted) | $4.8M | $14.1M | $16.0M | $16.5M | $15.4M | $15.2M | $16.2M | ||
| Shares Outstanding | $70.1M | $60.4M | $61.9M | $251.2M | $245.3M | $7.0M | $14.5M | ||
| Basic EPS | $10.88 | $8.64 | $37.6 | $8.8 | $-18.72 | $-2.08 | $-4.64 | ||
| Basic EPS (Continuing Operations) | $10.88 | $8.64 | $37.6 | $8.8 | $-18.72 | $-2.08 | $-4.64 | ||
| Diluted EPS | $10.4 | $8.16 | $35.84 | $8.32 | $-18.72 | $-2.05 | $-4.64 | ||
| Diluted EPS (Continuing Operations) | $10.4 | $8.16 | $35.84 | $8.32 | $-18.72 | $-2.05 | $-4.64 | ||
| Dividend Per Share | -- | -- | -- | -- | $0.03 | -- | -- | ||
| OTHER METRICS | |||||||||
| Accretion On Preferred Stock | $41.3M | $4.6M | -- | -- | -- | -- | -- | ||
| Accrued Preferred Stock Dividends | -- | $209.8M | -- | -- | -- | -- | -- | ||
| Commission Expenses | $80.3M | -- | -- | -- | -- | -- | -- | ||
| Development Expense | $80.3M | -- | -- | -- | -- | -- | -- | ||
| Earnings from equity interest | $2.8M | $1.7M | $-1.1M | $6.4M | $2.6M | $8.4M | -- | ||
| Earnings From Equity Interest Net Of Tax | $2.8M | $1.7M | $-1.1M | $6.4M | $2.6M | $8.4M | -- | ||
| Fees | -- | $-7.6M | -- | -- | -- | -- | -- | ||
| Minority Interests | $587.0K | $3.7M | $1.8M | $851.0K | $693.0K | $66.0K | $75.0K | ||
| Net Operating Interest Income Expense | $3.0M | $11.6M | $33.5M | -- | -- | -- | -- | ||
| Other Costof Revenue | -- | -- | -- | -- | -- | $260.5M | $112.4M | ||
| Other Gand A | $114.9M | $214.0M | $250.9M | $40.5M | $34.2M | $26.8M | $24.9M | ||
| Other Impairment Of Capital Assets | -- | $-4.1M | $2.6M | -- | $2.0M | -- | -- | ||
| Otherunder Preferred Stock Dividend | $41.3M | $214.3M | -- | -- | -- | -- | -- | ||
| Preferred Stock Dividends | $41.3M | $214.3M | -- | -- | -- | -- | -- | ||
| Rent And Landing Fees | $114.9M | $214.0M | $250.9M | $40.5M | $34.2M | -- | -- | ||
| Selling Expense | $44.0M | $96.5M | $182.0M | $68.8M | $66.7M | -- | -- | ||
| Write Down | -- | $-3.5M | -- | -- | -- | -- | -- | ||
| Write Off | -- | -- | $2.6M | -- | -- | -- | -- | ||
| Othspecchg | -- | $7.6M | -- | -- | -- | -- | -- | ||
| Restruct | -- | $12.2M | -- | -- | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ZEPP | $49.18 | -4.1% | 208.92K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Zepp Health Corporation American depositary shares each representing sixteen Class A Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW